Anbio Biotechnology Cost of Revenue
Anbio Biotechnology (NNNN) reported Cost of Revenue of $1.10 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-04-07
| Period end | Cost of Revenue 12 month |
|---|---|
| 2025-12-31 | $1.10M 20-F · filed 2026-04-07 |
| 2024-12-31 | $2.30M 20-F · filed 2026-04-07 |
| 2023-12-31 | $3.35M 20-F · filed 2026-04-07 |
| 2022-12-31 | $10.98M 20-F · filed 2025-04-28 |